(5-Methoxy-1H-benzoimidazol-2-yl)-methanol, 95.0%, 5g

DL-beta-Amino adipic acid, 97.0%, 5g

tert-Butyl 1-(cyclobutanecarbonyl)piperidin-4-ylcarbamate, 95.0%, 1g

6-(Pyrrolidin-1-yl)pyridine-3,4-diamine, 97%, 1g

2-Aminobenzene-1,4-diol hydrochloride, 95.0%, 5g

(9,9-Dioctyl-9h-fluorene-2,7-diyl)diboronic acid, 97%, 5g

Plan PLMi 20x/0,40 objetivo IOS corregido al infinito. Distancia de trabajo 8,8 mm

1-(4-Bromo-3-nitrophenyl)ethanone, 95.0%, 25g

METHYL 4-(2-(BENZYLOXY)ACETAMIDO)-2-HYDROXYBENZOATE, 95.0%, 1g

4-Bromo-2,6-dimethylbenzoic acid, 95.0%, 25g

ETHYL 3-(5-AMINO-6-BROMOPYRIDIN-2-YL)BENZOATE, 95.0%, 250mg

5,6-Dihydro-1H-imidazo[1,2-a]imidazole, 97%, 1g

N-(2-Fluorophenyl)-3-oxobutyramide>98.0%(N)200mg